NZ503418A - Use of dimethylformamide in the modulation of immune responses - Google Patents

Use of dimethylformamide in the modulation of immune responses

Info

Publication number
NZ503418A
NZ503418A NZ503418A NZ50341898A NZ503418A NZ 503418 A NZ503418 A NZ 503418A NZ 503418 A NZ503418 A NZ 503418A NZ 50341898 A NZ50341898 A NZ 50341898A NZ 503418 A NZ503418 A NZ 503418A
Authority
NZ
New Zealand
Prior art keywords
dimethylformamide
modulation
immune responses
immune
responses
Prior art date
Application number
NZ503418A
Inventor
Carl John Landauer
Preez Gabriel Johannes Du
Volker Reinhard Schillack
Derrick Cecil Attfield
Den Bogaarden Johannes Bey Van
Original Assignee
Frangold Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frangold Holdings Ltd filed Critical Frangold Holdings Ltd
Publication of NZ503418A publication Critical patent/NZ503418A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ503418A 1997-09-16 1998-09-16 Use of dimethylformamide in the modulation of immune responses NZ503418A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
PCT/US1998/019126 WO1999013885A1 (en) 1997-09-16 1998-09-16 Modulation of immune responses

Publications (1)

Publication Number Publication Date
NZ503418A true NZ503418A (en) 2001-02-23

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ503418A NZ503418A (en) 1997-09-16 1998-09-16 Use of dimethylformamide in the modulation of immune responses

Country Status (10)

Country Link
EP (1) EP1019063A4 (en)
JP (1) JP2001516721A (en)
CN (1) CN1279612A (en)
AU (1) AU737867B2 (en)
BR (1) BR9812321A (en)
CA (1) CA2304119A1 (en)
IL (1) IL135091A0 (en)
NO (1) NO20001341L (en)
NZ (1) NZ503418A (en)
WO (1) WO1999013885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
AU737867B2 (en) 2001-09-06
BR9812321A (en) 2000-09-05
JP2001516721A (en) 2001-10-02
CN1279612A (en) 2001-01-10
EP1019063A4 (en) 2003-09-03
NO20001341L (en) 2000-05-16
AU9389098A (en) 1999-04-05
WO1999013885A1 (en) 1999-03-25
EP1019063A1 (en) 2000-07-19
CA2304119A1 (en) 1999-03-25
NO20001341D0 (en) 2000-03-15
IL135091A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
ZA9711141B (en) Novel ketobenzamides and their use
DE69834346D1 (en) Proteinexpression in baculovirus-vektor expressionsystemen
PL335258A1 (en) Arylamine-condensed pyridines and pyrimidines
HRP970349B1 (en) Sulfonamides and their use
ZA988336B (en) Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
EP0894807A4 (en) GPIb-LIPID COMPLEX AND USES THEREOF
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
ZA958634B (en) Cookware
EP0934749A4 (en) Outfit supporting member and outfit made by using the same
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
PL332087A1 (en) Proteinous kinases and their application
AU8486098A (en) Waterproof connector and waterproofing-housing member used in the same
IL123535A0 (en) Benzoxazindione derivatives and their use
NZ503418A (en) Use of dimethylformamide in the modulation of immune responses
GB9713902D0 (en) Heating refreshments
GB9623539D0 (en) Enzymes and their use
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
EP0998578A4 (en) Sel-10 AND USES THEREOF
TW572247U (en) Heat sink and apparatus with the same
GB9716901D0 (en) Improvements in spectacles or the like
ZA988454B (en) Modulation of immune responses
GB9715323D0 (en) Piperidinecarboxamides and their use
DE29717210U1 (en) Serving and side table
GB9714382D0 (en) Enzymes and their use

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: NAMIBIAN MEDICAL INVESTMENTS PTY LIMITED, NA

Free format text: OLD OWNER(S): FRANGOLD HOLDINGS LIMITED

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired